ACADIA Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
CEOCatherine Owen Adams
CEOCatherine Owen Adams
Employees654
Employees654
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1993
Founded1993
Employees654
Employees654
ACAD Key Statistics
Market cap4.20B
Market cap4.20B
Price-Earnings ratio16.11
Price-Earnings ratio16.11
Dividend yield—
Dividend yield—
Average volume1.34M
Average volume1.34M
High today$25.21
High today$25.21
Low today$24.59
Low today$24.59
Open price$24.74
Open price$24.74
Volume1.03M
Volume1.03M
52 Week high$26.65
52 Week high$26.65
52 Week low$13.40
52 Week low$13.40
Stock Snapshot
With a market cap of 4.2B, ACADIA Pharmaceuticals(ACAD) trades at $24.85. The stock has a price-to-earnings ratio of 16.11.
On 2025-12-01, ACADIA Pharmaceuticals(ACAD) stock moved within a range of $24.59 to $25.21. With shares now at $24.85, the stock is trading +1.1% above its intraday low and -1.4% below the session's peak.
Trading activity shows a volume of 1.03M, compared to an average daily volume of 1.34M.
Over the past 52 weeks, ACADIA Pharmaceuticals(ACAD) stock has traded between a high of $26.65 and a low of $13.40.
Over the past 52 weeks, ACADIA Pharmaceuticals(ACAD) stock has traded between a high of $26.65 and a low of $13.40.
Analyst ratings
65%
of 20 ratingsBuy
65%
Hold
30%
Sell
5%
People also own
Based on the portfolios of people who own ACAD. This list is generated using Robinhood data, and it’s not a recommendation.